TNDM Tandem Diabetes Care
$16.16 -2.18%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-2.18%
YTD
+11.30%
P/E
—
P/B
9.6
ROE
-46%
Div yield
—
Beta
1
Market cap
$1.1B
RSI (14)
38
Next earnings
Nov 4, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$16.77
Close
$16.16
VWAP (n/a)
—
Day high
$17.05
Day low
$15.94
Volume
1.5M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Tandem Diabetes Care (TNDM) Is Up 7.2% After International Launch Of Mobi Insulin Pump System
Yahoo Finance · Oct 1
Q2 Earnings Highlights: Tandem Diabetes (NASDAQ:TNDM) Vs The Rest Of The Healthcare Technology Stocks
Yahoo Finance · Sep 30
Is Tandem Diabetes Care (TNDM) Undervalued As Investors Weigh Its 34% One Year Return?
Yahoo Finance · Sep 20
Tandem Diabetes Care (TNDM) Soars 7.7%: Is Further Upside Left in the Stock?
Yahoo Finance · Sep 17
Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now
Yahoo Finance · Sep 9
Tandem Diabetes Care Maps Growth Plan With Pharmacy Shift and Tubeless Mobi
Yahoo Finance · Aug 18
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Aug 6, 2026 View → 8-K Aug 6, 2026 View → 8-K May 21, 2026 View → 8-K May 15, 2026 View → 10-Q May 7, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell TNDM. Try it in the Lab to size a position and see the risk.